V. Roy

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

A. Chanan-Khan, V. Roy, S. Ansell, 2016, Blood Cancer Journal.

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

A. Dispenzieri, S. Rajkumar, S Kumar, 2015, Blood Cancer Journal.

The H 3 K 27 me 3 demethylase UTX is a gender-speci fi c tumor suppressor in T-cell acute lymphoblastic leukemia

Konstantinos J. Mavrakis, Ari, Pieter, 2014 .